Covidien Expands Oximetry Biz With Somanetics Acquisition
This article was originally published in The Gray Sheet
Covidien will expand its oximetry offerings through the purchase of Invos patient monitor manufacturer Somanetics for $250 million
You may also be interested in...
Newly acquired Oridion Microstream exhaled carbon dioxide measurement technology dovetails with Covidien’s pulse oximetry and other patient monitoring products.
Deal worth $325 million bolsters Covidien’s energy-based product offerings with Barrx Medical’s radiofrequency energy-based HaloFlex system for preventing esophageal cancer.
Hologic 3D mammography